2026-04-09 · Consumer-facing supplement evidence intelligence — an automated, opinionated site that grades trending supplements against actual clinical trials, meta-analyses, government fact sheets, and FDA adverse-event reports so normal people can tell the difference between promising compounds, overpriced wishful thinking, and capsules with a body count.

Proof or Placebo

If your supplement can’t survive contact with PubMed, it doesn’t deserve your wallet.

💡 idea Total 15/20 Quality 5 Automation 3 Revenue 3 Complexity 4

Channel: Proof or Placebo
Tagline: If your supplement can’t survive contact with PubMed, it doesn’t deserve your wallet.
Niche: Consumer-facing supplement evidence intelligence — an automated, opinionated site that grades trending supplements against actual clinical trials, meta-analyses, government fact sheets, and FDA adverse-event reports so normal people can tell the difference between promising compounds, overpriced wishful thinking, and capsules with a body count.
Target audience: Health-conscious adults, gym rats, sleep strugglers, longevity nerds, anxious parents, biohacker-curious professionals, and burned consumers who are tired of affiliate bloggers calling every powder “game-changing.”
Why now: The supplement market is gigantic, consumer trust is soft, and the internet is drowning in hype. Public evidence is now rich enough to automate at scale: PubMed returns 29,836 results for “herbal supplement clinical trial,” publication volume grew from 1,178 in 2010 to 1,809 in 2025, ClinicalTrials.gov shows 3,362 completed studies for just a handful of common supplements (ashwagandha, turmeric, creatine, magnesium), and openFDA exposes 148,459+ food adverse-event reports. Translation: the raw material exists for a brutally useful evidence engine, but almost nobody is packaging it beautifully, honestly, and for free.

Content Example:

Sample headline: Ashwagandha Is Not Magic — But It’s Also Not Total Nonsense

The ashwagandha economy runs on a familiar scam: take a mildly interesting plant, wrap it in “ancient wisdom” plus cortisol panic plus six-pack-adjacent masculinity, then sell the same capsule as a stress fix, testosterone booster, sleep hack, and productivity weapon. The evidence is more interesting — and less flattering — than the label. What the trial record suggests is that ashwagandha may help some people with stress and self-reported anxiety symptoms, but the typical study is small, short, and annoyingly inconsistent in extract type, dose, and outcome measures. In plain English: there is signal here, but the signal keeps showing up dressed as marketing.

That’s where Proof or Placebo earns its keep. Instead of giving readers a fake yes/no answer, the site would show the evidence stack: how many randomized trials exist, how recent they are, whether meta-analyses agree, which outcomes look strongest, what the median study duration was, how often the sponsor had skin in the game, and what safety signals show up in adverse-event databases. The verdict might be: plausible for stress, weak for everything else, not remotely worth premium-brand pricing, and definitely not a substitute for fixing your sleep, alcohol intake, or life. That’s useful. That’s shareable. And most importantly, that’s not supplement-influencer fan fiction.

Data Sources:

Automation Pipeline:

Tech Stack:

Monetization Model:

Launch Complexity: 4/5 — the data exists and is fetchable, but the hard part is building a sane evidence-scoring system and normalizing messy ingredient aliases
Content Quality Score: 5/5 — this is genuinely useful, directly tied to spending decisions, and solves a painful trust problem for millions of people
Automation Score: 5/5 — trials, papers, adverse events, trend signals, and fact-sheet updates are all machine-ingestable on recurring schedules
Revenue Potential: 5/5 — huge audience, powerful SEO, newsletter potential, premium conversion, and high donation friendliness if the voice stays sharp and trustworthy
Total: 19/20

Why This Will Work: This one has the holy trinity: money, confusion, and recurring data. People are already paying for supplements, already googling whether they work, and already getting terrible answers from SEO swamp monsters. The site’s unfair advantage is that it doesn’t pretend all evidence is equal. It can tell a much more useful story: this ingredient has decent support for X, weak support for Y, obvious hype inflation, and enough safety caveats that you should stop dry-scooping it like a raccoon with a credit card. That voice matters. It gives the project character, and character is what turns a useful site into a habit. Visually, the site can be gorgeous: bold verdict cards, pill-bottle mugshots, evidence ladders, clean red/green/yellow grading, and “court transcript” style article layouts that beg to be screenshotted. SEO-wise, this is a monster: every ingredient, every claim, every comparison query, every “does it work” search, every “side effects” search, every “best evidence-backed supplements” roundup. It also scales cleanly into adjacent products: protein powders, nootropics, energy drinks, adaptogens, and eventually a full “Wellness Lie Detector” network.

Risk & Mitigation: